OPTOMED.HEOPTOMED.HEHEL
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +39.32% | +20.86% | +9.70% | +42.07% | -5.63% |
| Gross Profit Growth | +34.56% | +21.69% | +2.21% | +61.17% | -122.79% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +11.78% | +11.91% | +12.03% | +8.00% | +6.08% |
| Weighted Average Shares Diluted Growth | +11.78% | +11.91% | +12.03% | +8.00% | +6.08% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -138.99% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +2.41% | -6.54% | -3.32% | +11.84% | +6.34% |
| Inventory Growth | -30.46% | -38.31% | -8.70% | -8.67% | +21.47% |
| Asset Growth | +9.29% | +11.15% | -14.78% | -15.75% | +0.60% |
| Book Value per Share Growth | +3.85% | +4.45% | -23.83% | -24.13% | -4.22% |
| Debt Growth | -21.57% | -21.84% | -23.75% | -24.59% | -6.93% |
| R&D Expense Growth | +144.19% | +97.47% | +7.69% | -45.90% | +60.00% |
| SG&A Expenses Growth | +83.71% | +36.43% | -33.74% | +151.84% | -23.96% |